Last update:

Weight management news

How skimping on sleep leads to weight gain

People who shortened their sleep by around 80 minutes a night for six weeks gained weight—1 pound on average—and were more sedentary, researchers at Columbia University Vagelos College of Physicians and Surgeons found.

Modest sleep loss linked to weight gain in adults with high cardiometabolic risk

A pooled analysis of two randomized trials found that decreasing sleep by just 1.5 hours each night was associated with increases in body weight, waist circumference and sedentary time in adults with elevated cardiometabolic ...

Resetting psoriasis memory may help body stop repeat flare-ups

Stress, bad weather, strep throat, alcohol or cuts—there are a number of triggers that can set off psoriasis. At the same time, a great deal is happening in research on this skin disease, and new ways of controlling the immune ...

New obesity figures highlight the income divide

The number of obese adults in England rose from 26% in 2019 to 30% in 2025, according to a new analysis of 55 million people. Nearly 1 in 3 adults are now obese. But averages hide a lot, and behind this one are two very different ...

7 things to know about Medicare's new GLP-1 coverage

For decades, it's been against the law for Medicare to pay for weight-loss medication. But that changed on July 1, with the launch of a new program called Bridge. It gives some people over 65, or who have Medicare for other ...

Stronger focus on nutrition needed in eating disorder recovery

Overreliance on body mass index (BMI) to measure recovery from eating disorders has sparked calls for better assessment methods. University of Queensland researchers reviewed 60 studies from five databases across 16 countries ...

Excess belly fat linked to faster biological aging

New research suggests that higher levels of visceral fat, the fat stored deep in the abdomen, could contribute to faster biological aging in middle-aged adults. Adjunct Associate Professors Jennie Hui and Kun Zhu, from The ...

Will GLP-1s lead to fewer prescriptions for older adults?

As people age, they often develop chronic conditions, many of which need to be managed with multiple prescription medications. While medications are important for disease management, polypharmacy poses an increased risk for ...

New oral GLP-1 drug delivers up to 12% weight loss in 36 weeks

A new strategy for delivering GLP-1 drugs to patients with obesity or who were overweight resulted in up to a 12% reduction in body weight after 36 weeks, according to a randomized phase II clinical trial published in Nature ...

'Food noise' discussion on social media helps define the term

With the rise of weight-loss drugs such as GLP-1 medications in recent years, the phrase "food noise" has taken off, particularly in conversations about health and wellness on social media. While thinking about food during ...

Can't stick to a diet? Try intermittent fasting for weight loss

Yo-yo dieters who struggle to lose weight and keep it off may achieve better results by following an intermittent fasting diet, rather than traditional calorie counting. An Adelaide University study focusing on the psychological ...

Why weight‑loss drugs don't work for some people

Weight-loss jabs are the latest craze for shedding a few pounds. Their effect has been dramatic, with drugs such as Ozempic and Wegovy (semaglutide) causing users to lose up to 15% of their body fat on average.

Beyond GLP-1s: The next chapter of obesity care

The rapid rise of GLP-1 medications such as semaglutide and tirzepatide has transformed obesity treatment. Still, experts say medications alone are not enough to address one of the nation's most pressing chronic diseases.

An economic case for teen weight-loss surgery

Metabolic and bariatric surgery for teens with severe obesity was found to be cost-effective over 10 years, according to a new analysis from Ann & Robert H. Lurie Children's Hospital of Chicago published in JAMA Network Open. ...

Semaglutide linked to lower bone fracture risk

In people with type 2 diabetes, semaglutide was associated with a 15% reduction in bone fractures and greater weight loss compared with other anti-obesity medications, according to a study presented at ENDO 2026, the Endocrine ...